according to news-medical
Batavia Biosciences receives $8 million grant to develop safe, affordable rotavirus vaccine
Batavia Biosciences receives $8 million grant to develop safe, affordable rotavirus vaccine
Batavia Biosciences received an $8 million grant from the Bill & Melinda Gates Foundation to develop a low cost manufacturing process to bring an affordable rotavirus vaccine to the global health market.This vaccine aims to save many young children's lives worldwide.Rotavirus infection, associated with severe vomiting and diarrhea, is the second largest infectious cause of death in young children.
as well cnbc
Here's why it's been really hard to develop a vaccine for RSV
Here's why it's been really hard to develop a vaccine for RSV
More than $1.5 billion vanished from vaccine developer Novavax's market value almost instantaneously Thursday afternoon after a late-stage trial of its vaccine for a common respiratory virus failed.It's the worst nightmare of investors in biotech, but also a serious blow to public health.The company was trying to tackle a problem that's thwarted medicine for more than half a century.
not to mention thehindu
Sun Pharma signs deal to develop dengue vaccine
Sun Pharma signs deal to develop dengue vaccine
India's largest pharmaceutical company, Sun Pharma, has signed a deal with the Delhi unit of the International Centre for Genetic Engineering and Biotechnology (ICGEB) to develop a dengue vaccine, multiple sources confirmed to The Hindu.An announcement is formally expected in Delhi next month, said a person associated with the deal.This would be the first time a vaccine developed entirely in India for a vector-borne disease has been advanced for clinical development in India.
No comments:
Post a Comment